Twist Bioscience Corporation (TWST), a provider of high-quality synthetic DNA using its silicon platform, said on Friday that it has appointed Adam Laponis as its Chief Financial Officer.
Laponis joins Twist from Eargo, Inc., where he served as CFO. Prior to Eargo, he was Vice President, Worldwide Financial Planning and Analysis and Business Operations at Tesla, Inc.
Earlier, Laponis served as Vice President, Finance and CFO, cardiovascular care at Cardinal Health as the finance leader for the worldwide Cordis Cardiovascular business.
TWST was trading down at 6.40 percent at $31.41 per share in the pre-market trade on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.